Skip to content Skip to a section
People and place

Immune diversity (HLA) in 19: COVID-19 outcome disparities in US cities

Black and Latino excess mortality linked to frontline jobs and comorbidity — not mystical racial immunity. Keep Immune diversity (HLA) with “COVID-19 outcome disparities in US cities” and 19 from 19. Ashkenazi BRCA vs HLA confusion in pop discourse

Transplant medicine matches alleles, not folk races. Use this page to deflate “racial immunity” talk. Human immune genetics is individual and local. Folk races are bad medical categories. Pathogen pressure and mating patterns maintain many alleles. Outcomes track exposure, comorbidity and health systems more than mystical race immunity.

Matching is allelic; ancestry may correlate weakly but clinicians type alleles. See malaria-adaptations — classic selection stories, still not a league of types. Public health logistics beat genetic fatalism. Malaria-adaptations; genetic-structure; race-is-not-biology. Genetic immunology data is sensitive — consent matters.

HLA molecules present peptides to T cells; many alleles mean many presentation styles. Heterozygote advantages are often hypothesized under infection pressure. Linkage disequilibrium complicates stories. Clinical typing beats self-identified race. Allele frequencies differ by region because epidemics and demography differed.

Fold the league table. Keep 19, “COVID-19 outcome disparities in US cities,” and 19 for Immune diversity (HLA). Keep Immune diversity (HLA) with “COVID-19 outcome disparities in US cities” and 19 from 19. 1919

Figures to keep

Year of the account
19
Figure beside it
19
Topic
Immune diversity (HLA)
Line about the life
COVID-19 outcome disparities in US cities

Malaria adaptations in 6: G6PD deficiency geographyNext essayAll 1000 essays1000